Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $11.64 and last traded at $11.64, with a volume of 7500 shares. The stock had previously closed at $11.64.
Ono Pharmaceutical Stock Performance
The business’s 50 day simple moving average is $13.93 and its 200-day simple moving average is $14.11. The company has a market cap of $5.98 billion, a price-to-earnings ratio of 8.69 and a beta of 0.55.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- High Flyers: 3 Natural Gas Stocks for March 2022
- Palantir Cracks $50, Is There Still Time to Get on Board?
- 3 Small Caps With Big Return Potential
- Insider Buying Signals Upside for These 3 Stocks
- High Dividend REITs: Are They an Ideal Way to Diversify?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
